A non-targeted screening and identification method for organic effect components in atmospheric fine particulate matter

Through high-resolution time-of-flight mass spectrometry and effect-oriented analysis methods, the problem of difficulty in identifying organic components in PM2.5 was solved, and a comprehensive non-targeted screening and identification of organic components in PM2.5 was achieved, and key toxicities were screened out. The substance overcomes the shortcomings of traditional methods and provides a research method on the toxicity risks and pathogenic mechanisms of organic components in complex atmospheric PM2.5.

CN115950965BActive Publication Date: 2024-11-19SHANXI UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211088203.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-07
Publication Date
2024-11-19
Estimated Expiration
2042-09-07

AI Technical Summary

Technical Problem

The prior art is difficult to effectively identify and identify the toxic effects of organic components in PM2.5, which leads to difficulty in targeted analysis and identification. Most of the studies focus on a few compounds and lack a comprehensive understanding of complex particulate matter.

Method used

The high-resolution, high-sensitivity gas chromatography-high-resolution time-of-flight mass spectrometry GC-HR-ToF-MS binding effect-oriented analysis method was adopted to perform non-targeted screening and identification of atmospheric fine particles, and the full scan was performed using EI/ECNI ionization mode. Cryotoxicity components were screened in combination with cytotoxicology models.

Benefits of technology

A comprehensive non-targeted identification of organic components in PM2.5 was achieved, and key toxic substances were screened out, and the detection blindness in traditional methods and the uncertainty of effect substances in biological testing was overcome. In order to explore the complex atmosphere PM2.5 The potential toxicity risks and pathogenic mechanisms of different organic components in the present invention provide methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115950965B_ABST
    Figure CN115950965B_ABST
Patent Text Reader

Abstract

The present invention belongs to the technical field of new environmental pollutant screening. 2.5 The organic matter carried is of various types and complex composition, which leads to problems such as blindness in chemical analysis and uncertainty of effect substances in biological tests. This paper provides a non-targeted screening and identification method for effect components in the organic components of atmospheric fine particulate matter. Using GC‑HR‑ToF‑MS and comprehensive EI / ECNI ionization modes, the organic components of atmospheric fine particulate matter are comprehensively non-targeted identified, and effect-guided analysis EDA is used to screen and identify key toxic substances based on key toxicity. It is suitable for the screening of other effect components such as cardiovascular toxicity and neurotoxicity. It can not only test the biological effects of samples, but also identify effectors, avoid blindness in chemical analysis and uncertainty in effect substances in biological tests, and provide a basis for exploring complex atmospheric PM 2.5 It provides a method to investigate the potential toxicity risks and pathogenic mechanisms of different organic components in water.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of new environmental pollutant screening, and specifically relates to a non-targeted screening and identification method for organic effect components in atmospheric fine particulate matter. Background Art

[0002] PM 2.5 It is an atmospheric suspended particulate matter with an aerodynamic diameter of less than 2.5 microns. It is an inhomogeneous mixture of solid and liquid particles from various sources suspended in the air, and its chemical composition changes with time and space. Many compounds bound to particulate matter have been found to be genotoxic, mutagenic, and carcinogenic. A large amount of epidemiological and experimental evidence shows that PM 2.5 Pollution is associated with a variety of health risks, such as respiratory diseases, cardiovascular diseases, lung cancer and nervous system damage. Different components of particulate matter have different toxic effects and mechanisms of action. Among them, organic components are the most important factor affecting PM 2.5 One of the important factors of toxic effects. Although toxicological studies have shown that different components contribute differently to the cytotoxicity, oxidative stress, reactive oxygen species (ROS) generation, DNA damage and pro-inflammatory effects of PM, it is still impossible to effectively explore the contribution of different components to the overall toxicity of particulate matter, and there is a lack of a complete understanding of the toxic mechanism of particulate matter. In addition, due to the rich variety of organic components in particulate matter, accounting for about 19%-60% of particulate matter, but only 5%-10% of them have been identified, it leads to targeted analysis to identify PM 2.5 The organic components in particulate matter have reached a bottleneck, and most of the current research focuses on polycyclic aromatic hydrocarbons and their derivatives, polychlorinated biphenyl ethers, etc. Therefore, it is necessary to comprehensively identify and identify the organic components in particulate matter and analyze their health effects. The high-throughput, high-resolution and high-sensitivity GC-HR-ToF-MS non-targeted screening technology has the advantages of screening trace substances over a large range and qualitatively identifying unknown compounds, so it can be used as an important tool for identifying organic components in particulate matter.

[0003] Since particulate matter carries a wide variety of organic matter with complex composition, it is unrealistic to comprehensively analyze all organic matter and its health effects. Summary of the invention

[0004] The present invention is to solve the problem of PM 2.5The loaded organic matter is of various types and complex composition, which leads to problems such as blindness in chemical analysis and uncertainty in effect substances in biological tests. This paper provides a non-targeted screening and identification method for organic effect components in atmospheric fine particulate matter. High-resolution and high-sensitivity gas chromatography-high-resolution time-of-flight mass spectrometry GC-HR-ToF-MS is used to perform comprehensive non-targeted identification of its organic components, and at the same time, the effect-oriented analysis method is combined to separate and identify key toxic substances in atmospheric fine particulate matter.

[0005] The present invention is achieved by the following technical scheme: a method for non-targeted screening and identification of organic effect components in atmospheric fine particulate matter, which utilizes high-resolution and high-sensitivity gas chromatography-high-resolution time-of-flight mass spectrometry GC-HR-ToF-MS and comprehensive EI / ECNI ionization modes to perform comprehensive non-targeted identification of organic components in atmospheric fine particulate matter, and utilizes effect-guided analysis EDA, with key toxicity as a guide, to screen and identify key toxic substances in atmospheric fine particulate matter.

[0006] The specific method is:

[0007] (1) Extraction of total organic components from atmospheric fine particulate matter: Use a large-flow atmospheric particulate matter sampler to collect particulate matter samples and establish a PM2.5-based accelerated solvent extractor (ASE) 2.5 The non-targeted full extraction method of organic components is used to extract organic components loaded by atmospheric fine particulate matter;

[0008] Specifically divided into: polar component extraction: extraction agent methanol, extraction temperature 100℃, heating time 5 min, equilibrium extraction time 10 min, cycle number 2, rinse volume 30%, perfusion time 60s;

[0009] Extraction of non-polar components: the extractant was a mixed solution of n-hexane / acetone in a volume ratio of 1:1, the extraction temperature was 100°C, the heating time was 5 min, the equilibrium extraction time was 10 min, the number of cycles was 2, the rinse volume was 30%, and the perfusion time was 60 s;

[0010] Combine the two extracts respectively, rotary evaporate and concentrate to constant weight with nitrogen blowing, and weigh the total weight of the extract by difference method;

[0011] (2) Separation of organic components of atmospheric fine particulate matter: A. The total organic components of atmospheric fine particulate matter extracted in step (1) were subjected to chromatographic fractionation by reversed phase liquid chromatography (RP-HPLC); the chromatographic collection time was calibrated using a PAHs mixed standard and a sulfonamide antibiotic mixed standard; the specific liquid phase method was as follows: instrument: QBH-LC; chromatographic column: Sunniest C18, 4.6 mm × 5 μm × 250 mm; UV detector wavelength: 220 nm & 290 nm; mobile phase: A-pure water, B-acetonitrile, 1.0 ml / min; gradient: 0 min, 50% B; 2.5 min, 50% B; 5.5 min, 100% B; 11.5 min, 100% B; 14.5 min, 50% B; 17 min, 50% B; the fraction collector adopted a time window mode to intermittently collect the primary sample;

[0012] Screening: The primary organic components obtained by fractionation were used to infect the corresponding in vitro cell models of toxicology, and the non-specific indicators corresponding to the cells were used as toxicological endpoints. The qRT-PCR technology was combined to detect the effects of the primary organic components on the expression of marker factors of the epithelial-mesenchymal transition (EMT) process of cells (such as E-cad, N-cad, Fib, Vim), and the toxic components of fine particles were preliminarily screened and subjected to secondary fractionation;

[0013] B. For samples that require secondary fractionation, the solvent is replaced with a mixed solution of acetone / ethyl acetate in a volume ratio of 1:1, and normal phase liquid chromatography NP-HPLC chromatographic fractionation is performed; the chromatographic collection time is also calibrated using a PAHs mixed standard and a sulfonamide antibiotic mixed standard; the specific liquid phase method is as follows: instrument: QBH-LC; chromatographic column: Intersil SIL-100A, 4.6 mm × 5 μm× 250 mm; UV detector wavelength: 254 nm; mobile phase: A-n-hexane, 1.0 ml / min; isocratic elution: 100% A, 15 min; the fraction collector adopts the time window mode, and intermittent collection is performed to obtain secondary samples;

[0014] The secondary organic components obtained by fractionation were used to toxicate the corresponding in vitro cell models, and the corresponding non-specific indicators of the cells were used as toxicological endpoints to screen out the key toxic components on fine particles.

[0015] (3) Identification of key toxic components of atmospheric fine particulate matter: Using a gas chromatography-high resolution time-of-flight mass spectrometer (GC-HR-TOF-MS) instrument that combines gas chromatography with high-throughput and high-resolution mass spectrometry, use the EI / ECNI ionization modes to perform a full material scan of the key toxic components screened in step (2) to obtain a total ion flow diagram of all components containing chromatographic mass spectrometric information. Then, based on the high-resolution mass spectrometric fragmentation information and chromatographic retention time combined with mass spectrometric databases such as NIST, the chromatographic mass spectrometric information of each component in the total ion flow diagram is qualitatively analyzed to identify the key substances screened.

[0016] The non-specific indicators corresponding to the cells in step (2) are cell migration ability, survival rate or inflammatory index.

[0017] The in vitro cell model corresponding to the toxicology described in step (2) is human lung cancer A549 cells, and the non-specific indicator corresponding to the cells is cell migration ability.

[0018] The present invention provides a non-targeted screening and identification method for effect components in the organic components of atmospheric fine particulate matter, which is suitable for studying the screening of effect components in atmospheric fine particulate matter, such as cancer-promoting components, cardiovascular toxicity, neurotoxicity, etc. The present invention can not only comprehensively identify the organic substances carried by atmospheric fine particulate matter, but also use effect-oriented methods to screen out key effect components that cause specific diseases. Compared with traditional toxicology experiments, this study combines chemical analysis to link biological effects with effect pollutants, overcoming the shortcomings of single chemical analysis or single biological testing in the application of environmental samples. It can not only test the biological effects of samples, but also identify effectors, avoiding the blindness of detection in chemical analysis and the uncertainty of effector substances in biological testing, and providing a basis for exploring complex atmospheric PM 2.5 It provides a method to investigate the potential toxicity risks and pathogenic mechanisms of different organic components in water.

[0019] In order to screen and identify the key organic components of particulate matter that cause a specific disease, we used the principle of effect-directed analysis (EDA). The basic principles of EDA are as follows: Figure 1 Effect-oriented analysis is a set of analytical testing methods for complex organic pollutants. It combines biological testing with chemical analysis, takes biological effects as a guide, guides the separation of active components, and characterizes the components to identify effectors, and finally clarifies the biological effects and main effectors of the samples.

[0020] The method of the present invention combines toxicological experiments and chemical analysis, links biological effects with effect pollutants, overcomes the shortcomings of single chemical or single biological tests in environmental sample applications, can not only test the biological effects of samples, but also identify effect compounds, avoids the blindness of detection in chemical analysis and the uncertainty of effect substances in biological tests, and provides a new method for exploring complex atmospheric PM 2.5 The present invention uses effect-oriented analysis methods, combined with GC-HR-ToF-MS, to separate and identify key cancer-promoting effect components of particulate matter with lung cancer as a specific disease endpoint, so as to achieve targeted control of key cancer-promoting effect components of particulate matter. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 Provides a basic schematic diagram for effect-oriented analysis of EDA;

[0022] Figure 2 This is the RPLC primary fractionation chromatogram of the organic extract of the particulate matter sample;

[0023] Figure 3 It is a diagram of the effect of the first-stage fractionation sample on promoting tumor metastasis; in the figure: AB: Cell experimental effect diagram and data statistical diagram of the effect of exposure to the first-stage fractionation components of the organic extract of particulate matter samples on the in vitro metastasis ability of A549 cells, where AH is the first-stage fractionation components of the organic extract of particulate matter; C: The effect of exposure to the first-stage fractionation components of the organic extract of particulate matter samples on the expression of marker genes related to cell-mesenchymal transformation;

[0024] Figure 4 This is a sample effect diagram of the secondary fractionation of the first fractionation component D of the organic extract of the particulate matter sample;

[0025] Figure 5 It is a diagram of the effect of secondary fractionation samples on promoting tumor metastasis; in the figure: AB: cell experimental effect diagram and data statistical diagram of the effect of exposure to secondary fractionation components of organic extracts of particulate matter samples on the in vitro metastasis ability of A549 cells, among which D1 and D2 are the secondary fractionation products of the first-level fractionation component D of the organic extract of particulate matter; C: The effect of exposure to secondary fractionation components of organic extracts of particulate matter samples on the expression of marker genes related to cell mesenchymal transformation (EMT). DETAILED DESCRIPTION

[0026] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all the embodiments; based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0027] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs, and the disclosure and materials cited therein are hereby incorporated by reference.

[0028] Technical equivalents to the specific embodiments described that are apparent to those skilled in the art using no more than routine experimentation are intended to be encompassed by this application.

[0029] The experimental methods in the following examples are all conventional methods unless otherwise specified. The instruments and equipment used in the following examples are all conventional laboratory instruments and equipment unless otherwise specified; the experimental materials used in the following examples are all purchased from conventional biochemical reagent stores unless otherwise specified.

[0030] Example 1: A method for screening key effector organic components in atmospheric fine particulate matter that promote the development of lung cancer. This method uses lung cancer metastasis as the disease endpoint, screens out cancer-promoting organic components carried by atmospheric fine particulate matter based on the effect-directed analysis method (EDA), and uses high-resolution time-of-flight mass spectrometry for non-targeted identification, thereby accurately identifying key cancer-promoting components carried by atmospheric fine particulate matter. The basic principle of EDA is as follows Figure 1 As shown, the specific method is:

[0031] 1. Extraction of total organic components of atmospheric fine particulate matter: Use a large-flow atmospheric particulate matter sampler to collect particulate matter samples, combined with Jiang Xing et al. (Environ. Sci. Technol. 2019, 53, 10479−10486) 2.5 The extraction method for targeted analysis of organic pollutants of different properties in PM was established based on the accelerated solvent extractor ASE. 2.5 The non-targeted full extraction method of organic components is used to extract the organic components loaded by atmospheric fine particulate matter; the particulate matter used this time was collected from the rooftop of the School of Environment and Resources of Shanxi University during the winter heating period of 2018.

[0032] Specifically divided into: polar component extraction: extraction agent methanol, extraction temperature 100℃, heating time 5 min, equilibrium extraction time 10 min, cycle number 2, rinse volume 30%, perfusion time 60s;

[0033] Extraction of non-polar components: the extractant was a mixed solution of n-hexane / acetone in a volume ratio of 1:1, the extraction temperature was 100°C, the heating time was 5 min, the equilibrium extraction time was 10 min, the number of cycles was 2, the rinse volume was 30%, and the perfusion time was 60 s;

[0034] Combine the two extracts respectively, rotary evaporate and concentrate to constant weight with nitrogen blowing, and weigh the total weight of the extract by difference method;

[0035] 2. Separation of organic components of atmospheric fine particles:

[0036] A. The total organic components of atmospheric fine particulate matter extracted in step (1) were subjected to chromatographic fractionation by reversed phase liquid chromatography (RP-HPLC); the chromatographic collection time was calibrated using a PAHs mixed standard and a sulfonamide antibiotic mixed standard; the specific liquid phase method was as follows: instrument: QBH-LC; chromatographic column: Sunniest C18, 4.6 mm × 5 μm × 250 mm; UV detector wavelength: 220 nm & 290 nm; mobile phase: A-pure water, B-acetonitrile, 1.0 ml / min; gradient: 0 min, 50% B; 2.5 min, 50% B; 5.5 min, 100% B; 11.5 min, 100% B; 14.5 min, 50% B; 17 min, 50% B; the fraction collector adopted a time window mode, and a primary sample was collected every 1.5 minutes; the RPLC primary fractionation effect diagram of the particulate matter sample is shown in the figure below. Figure 2 shown.

[0037] Screening: Establish an in vitro cell model for cancer-promoting effect screening, and its subsequent characterization methods are as follows:

[0038] Through the scratch test, the effects of different organic fractions of particulate matter on the migration distance of A549 cells were visually monitored under the bright field condition of the microscope;

[0039] The qRT-PCR method was used to detect the expression of epithelial-mesenchymal transition-related mRNA in A549 cells after treatment with different organic fractions.

[0040] The primary organic components AH obtained by fractionation were used to infect the human lung cancer A549 cell model, and the corresponding migration ability of A549 cells was used as the toxicological endpoint. The effects of the primary organic components on the expression of marker factors of epithelial-mesenchymal transition process of A549 cells (such as E-cad, N-cad, Fib, Vim) were analyzed by qRT-PCR detection technology. The toxic components on fine particles were preliminarily screened and subjected to secondary fractionation. The tumor metastasis promoting effect of the primary fractionation samples was as follows: Figure 3 As shown, sample D caused the most significant increase in cell migration ability, and sample D induced the highest degree of change in the expression of epithelial-mesenchymal transition factors (E-cad, N-cad, Fib, Vim). Therefore, we believe that sample D may be the key component that induces the increase in A549 cell migration ability, and therefore further secondary fractionation was performed on sample D.

[0041] B. For sample D that needs secondary fractionation, the solvent is replaced with a mixed solution of acetone / ethyl acetate in a volume ratio of 1:1, and normal phase liquid chromatography NP-HPLC chromatographic fractionation is performed; the chromatographic collection time is also calibrated using a PAHs mixed standard and a sulfonamide antibiotic mixed standard; the specific liquid phase method is as follows: instrument: QBH-LC; chromatographic column: Intersil SIL-100A, 4.6 mm × 5 μm× 250 mm; UV detector wavelength: 254 nm; mobile phase: A-n-hexane, 1.0 ml / min; isocratic elution: 100% A, 15 min; the fraction collector adopts the time window mode, and a secondary sample is collected every 2 minutes; the NP-HPLC effect of the secondary fractionation sample is as follows Figure 4 shown.

[0042] The secondary organic components obtained by fractionation were used to infect human lung cancer A549 cells corresponding to toxicology, and the migration ability of A549 cells was used as the toxicological endpoint to screen out the components that promote tumor cell metastasis on fine particles; the tumor metastasis promoting effect of the secondary fractionation samples was as follows: Figure 5 As shown, sample D2 caused the most significant increase in cell migration ability, and sample D2 induced the highest degree of change in the expression of epithelial-mesenchymal transition factors (E-cad, N-cad, Fib, Vim). Therefore, we believe that sample D may be the key component that induces the increase in A549 cell migration ability, and therefore, we identified the components of sample D2.

[0043] 3. Identification of key toxic components of atmospheric fine particulate matter: Utilize a gas chromatography-high resolution time-of-flight mass spectrometer (GC-HR-TOF-MS) instrument that combines gas chromatography with high-throughput and high-resolution mass spectrometry, and use the two ionization modes of EI / ECNI to perform a full material scan on the key toxic components screened out in step (2) to obtain a total ion flow diagram of all components containing chromatographic mass spectrometric information. Then, based on the high-resolution mass spectrometric fragmentation information and chromatographic retention time combined with mass spectrometric databases such as NIST, characterize the chromatographic mass spectrometric information of each component in the total ion flow diagram, thereby identifying the key substances that screened out the cancer-promoting components of atmospheric fine particulate matter.

[0044] The results of identifying key components that promote tumor metastasis are shown in Table 1. The results show that 35 key components that promote lung tumor metastasis were initially obtained: (1) 7,7-dichloro-2-heptanone C7H 12 Cl2O; (2) diisopropyl methyl phosphate C7H 17 O3P; (3) 2-ethyl-5-methylfuran C7H 10 O; (4) N-(1-methylbutyrolactone)-formamide C6H 13 N; (5) 2-tert-butyltoluene C 11 H 16 ;(6)Methyl nonanoate C10 H 20 O2; (7) 4-aminopyrazolo[3,4-d]pyrimidine C5H5N5; (8) 4-tert-butylanisole C 11 H 16 O; (9) Methyl decanoate C 11 H 22 O2; (10) Methyl p-toluenesulfonate C8H 10 O3S; (11) dimethyl terephthalate C 10 H 10 O4; (12) Ethyl p-toluenesulfonate C9H 12 O3S; (13) 4-Methyl formate ethyl benzoate C 11 H 12 O4; (14) tributyl phosphate C 12 H 27 O4P; (15) N,N-dimethyl toluenesulfonamide C9H 13 NO2S; (16) N-methyl-p-toluenesulfonamide C8H 11 NO2S; (17) 12-Methyltridecanoate C 15 H 30 O2; (18) 2,2-dimethylpropyl 2,2-dimethylpropane thiosulfite C 10 H 22 OS2; (19) 4-amino-7-diethylamino-chromium-2-one C 13 H 16 N2O2; (20) Methyl palmitate C 17 H 34 O2; (21) diphenyl sulfone C 12 H 10 O2S; (22) dibutyl phthalate C 16 H 22 O4; (23) 4-ethyl-2,2,6,6-tetramethyl-3,5-heptanedione C 13 H 24 O2; (24) 2,6-naphthalenedicarboxylic acid dimethyl ester C 14 H 12 O4; (25) precocious hormone ⅡC 13 H 16 O3; (26) Bisphenol A dimethyl ether C 17 H 20 O2; (27) Valeric anhydride C 10 H 18 O3; (28) 2-Bromododecane C 12 H 25 Br; (29) 3-O-benzylestradiol C 25 H 30 O2; (30) 2-bromotetradecane C14 H 29 Br; (31) 6-chloro-3-biphenyl C 12 H9ClO; (32) 2-methyl-3-(2-chloro-5-hydroxyphenyl)-4(3H)-quinazolinone C 15 H 11 ClN2O2; (33) trihexylamine C 18 H 39 N; (34) 2,4,6-Tricyclohexylphenol C 24 H 36 O; (35) 2,2'-(1,2-phenylene)bipyridine C 16 H 12 N2.

[0045] 4. Further screening of key components that promote tumor metastasis

[0046] A total of 35 organic components were fully identified by high-throughput gas chromatography-high-resolution time-of-flight mass spectrometry (GC-HR-TOF-MS). Molecular docking was performed with the key transcriptional regulatory factors in the epithelial-mesenchymal transition process of these 35 organic components to compare their binding abilities. The docking results are shown in Table 1.

[0047] Table 1: Key components of tumor metastasis-promoting effects identified by GC-HRTOF-MS

[0048]

[0049]

[0050]

[0051]

[0052]

[0053] The molecular docking results of each component of sample D2 and the key transcription factors regulating the EMT process are shown in Table 2.

[0054] Table 2: Molecular docking results of each component of sample D2 and key transcription factors regulating the EMT process

[0055]

[0056]

[0057] Combined with the results shown in Table 2, the key effector components that promote tumor metastasis obtained by further screening through molecular docking are shown in Table 3.

[0058] Table 3 shows the key effector components that promote tumor metastasis obtained through further screening by molecular docking

[0059]

[0060] The key effect components that promote tumor metastasis in atmospheric fine particles that were finally identified and screened by the present invention are: (1) trihexylamine C 18 H 39 N; (2) 12-methyltridecanoic acid methyl ester C 15 H 30 O2; (3) tributyl phosphate C 12 H 27 O4P; (4) diphenyl sulfone C 12 H 10 O2S; (5) Methyl palmitate C 17 H 34 O2; (6) Methyl decanoate C 11 H 22 O2; (7) 2,6-naphthalenedicarboxylic acid dimethyl ester C 14 H 12 O4; (8) Bisphenol A dimethyl ether C 17 H 20 O2; (9) 4-amino-7-diethylamino-chromium-2-one C 13 H 16 N2O2; (10) dibutyl phthalate C 16 H 22 O4; (11) 2-bromotetradecane C 14 H 29 Br.

[0061] Through the method of the present invention, lung cancer is used as a specific disease endpoint to separate and identify the key cancer-promoting effect components of particulate matter, thereby achieving targeted control of the key cancer-promoting effect components of particulate matter. 2.5 It provides a method to investigate the potential toxicity risks and pathogenic mechanisms of different organic components in water.

[0062] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. A non-targeted screening and identification method for effect components in organic components of atmospheric fine particulate matter, characterized in that: Using high-resolution and high-sensitivity gas chromatography-high-resolution time-of-flight mass spectrometry GC-HR-ToF-MS and comprehensive EI / ECNI ionization modes, we can conduct comprehensive non-targeted identification of the organic components of atmospheric fine particles. We also use effect-directed analysis (EDA) to screen and identify key toxic substances in atmospheric fine particles based on key toxicity. The specific methods are as follows: (1) Extraction of total organic components from atmospheric fine particulate matter: Use a large-flow atmospheric particulate matter sampler to collect particulate matter samples and establish a PM2.5-based accelerated solvent extractor (ASE) 2.5 The non-targeted full extraction method of organic components is used to extract organic components loaded by atmospheric fine particulate matter; Specifically divided into: polar component extraction: extraction agent methanol, extraction temperature 100℃, heating time 5 min, equilibrium extraction time 10 min, cycle number 2, rinse volume 30%, perfusion time 60s; Extraction of non-polar components: the extractant was a mixed solution of n-hexane / acetone in a volume ratio of 1:1, the extraction temperature was 100°C, the heating time was 5 min, the equilibrium extraction time was 10 min, the number of cycles was 2, the rinse volume was 30%, and the perfusion time was 60 s; Combine the two extracts respectively, rotary evaporate and concentrate to constant weight with nitrogen blowing, and weigh the total weight of the extract by difference method; (2) Separation of organic components of atmospheric fine particulate matter: A. The total organic components of atmospheric fine particulate matter extracted in step (1) are subjected to chromatographic fractionation by reversed phase liquid chromatography (RP-HPLC); the chromatographic collection time is calibrated by using a PAHs mixed standard and a sulfonamide antibiotic mixed standard; the specific liquid phase method is as follows: Instrument: QBH-LC; Chromatographic column: Sunniest C18, 4.6 mm × 5 μm × 250 mm; UV detector wavelength: 220 nm & 290 nm; Mobile phase: A-pure water, B-acetonitrile, 1.0 ml / min; Gradient: 0 min, 50% B; 2.5 min, 50% B; 5.5 min, 100% B; 11.5 min, 100% B; 14.5 min, 50% B; 17 min, 50% B; The fraction collector adopts the time window mode to collect the primary sample intermittently; Screening: The primary organic components obtained by fractionation were used to infect the corresponding in vitro cell models of toxicology, and the non-specific indicators corresponding to the cells were used as toxicological endpoints. The qRT-PCR technology was combined to detect the effects of the primary organic components on the expression of marker factors of the epithelial-mesenchymal transition (EMT) process of cells, and the toxic components of fine particles were preliminarily screened and subjected to secondary fractionation; B. For samples that require secondary fractionation, the solvent is replaced with a mixed solution of acetone / ethyl acetate with a volume ratio of 1:1, and normal phase liquid chromatography NP-HPLC chromatographic fractionation is performed; the chromatographic collection time is also calibrated using a PAHs mixed standard and a sulfonamide antibiotic mixed standard; the specific liquid phase method is: Instrument: QBH-LC; chromatographic column: Intersil SIL-100A, 4.6 mm × 5 μm × 250 mm; UV detector wavelength: 254 nm; mobile phase: A-n-hexane, 1.0 ml / min; isocratic elution: 100% A, 15 min; The fraction collector adopts the time window mode to collect the secondary samples intermittently; The secondary organic components obtained by fractionation were used to toxicate the corresponding in vitro cell models, and the corresponding non-specific indicators of the cells were used as toxicological endpoints to screen out the key toxic components on fine particles. (3) Identification of key toxic components of atmospheric fine particulate matter: Using a gas chromatography-high resolution time-of-flight mass spectrometer (GC-HR-TOF-MS) instrument that combines gas chromatography with high-throughput and high-resolution mass spectrometry, use the EI / ECNI ionization modes to perform a full material scan on the key toxic components screened in step (2) to obtain a total ion flow diagram of all components containing chromatographic mass spectrometric information. Then, based on the high-resolution mass spectrometric fragmentation information and chromatographic retention time combined with the NIST mass spectrometric database, the chromatographic mass spectrometric information of each component in the total ion flow diagram is qualitatively analyzed to identify the key substances screened.

2. The method for non-targeted screening and identification of effect components in organic components of atmospheric fine particulate matter according to claim 1, characterized in that: The non-specific indicators corresponding to the cells in step (2) are cell migration ability, survival rate or inflammatory index.

3. The method for non-targeted screening and identification of effect components in organic components of atmospheric fine particulate matter according to claim 1, characterized in that: The in vitro cell model corresponding to the toxicology described in step (2) is human lung cancer A549 cells, and the non-specific indicator corresponding to the cells is cell migration ability.

4. The method for non-targeted screening and identification of effect components in organic components of atmospheric fine particulate matter according to claim 1, characterized in that: The marker factors of the cell epithelial-mesenchymal transition (EMT) process in step (2) are E-cad, N-cad, Fib, and Vim.